Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer.
about
Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumors.Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancerRecent developments in the pharmacological treatment of advanced pancreatic cancer.Advanced pancreatic cancer: is there a role for combination therapy?Phase II clinical trials on investigational drugs for the treatment of pancreatic cancersA multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancerFront-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I-II trial.HuangQin Decoction Attenuates CPT-11-Induced Gastrointestinal Toxicity by Regulating Bile Acids Metabolism Homeostasis.Preclinical Rationale for the Phase III Trials in Metastatic Pancreatic Cancer: Is Wishful Thinking Clouding Successful Drug Development for Pancreatic Cancer?Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6).
P2860
Q33387673-DFADD1AB-E378-40B7-B531-D51E053DA919Q34610496-5C686B1E-F557-415D-ACF1-47E8E4A150D0Q35144004-7EE253D8-F159-4C7A-B85D-1931A2DE66F3Q35576200-6CC5D126-CACA-49A9-BFB9-DA14EF37EE61Q36384541-B354E219-B470-4773-8A1C-DB5DCDD2EBA8Q36612255-4ECA9A6B-57E2-4BAF-BB81-44CC7FC4DD2CQ36614907-388AA711-E691-4130-9BB2-A3F24F73D596Q37727573-819A3F56-5DEC-49AD-A453-C800E6A0B829Q39022032-2EA9004E-4995-41F7-ABDF-3F8F31B04164Q48617362-59A9B257-61CA-4C4E-9D73-BFBF11A08C23
P2860
Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Treatment of pancreatic cancer ...... e Group for Pancreatic Cancer.
@ast
Treatment of pancreatic cancer ...... e Group for Pancreatic Cancer.
@en
type
label
Treatment of pancreatic cancer ...... e Group for Pancreatic Cancer.
@ast
Treatment of pancreatic cancer ...... e Group for Pancreatic Cancer.
@en
prefLabel
Treatment of pancreatic cancer ...... e Group for Pancreatic Cancer.
@ast
Treatment of pancreatic cancer ...... e Group for Pancreatic Cancer.
@en
P2093
P356
P1433
P1476
Treatment of pancreatic cancer ...... e Group for Pancreatic Cancer.
@en
P2093
C Kouroussis
D Janninis
G Aravantinos
G Foutzilas
G P Stathopoulos
Greek Cooperative Group for Pancreatic Cancer
J G Stathopoulos
N Androulakis
S K Rigatos
P304
P356
10.1093/ANNONC/MDG109
P577
2003-03-01T00:00:00Z